Shares have rebounded on Trump’s tariff retreat, but his erratic policy shifts could weigh on long-term return expectations.

Here’s what to know about the order and its potential impact on drug prices in the U.S. Could the Executive Order actually ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

President Trump’s announcement that the U.S. will ease sanctions on Syria could eventually facilitate the country’s recovery ...

Rasmussen suggests creating a new "D7" grouping of democracies, including the EU, UK, Canada, Australia, Japan, South Korea, ...

U.S. President Donald Trump has said he will lift long-standing sanctions on Syria that severed the country from the global ...

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...

European leaders say they are ready to place counter tariffs on some $106 billion of U.S. goods, including chemicals, ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Trump took aim at governments paying a fraction of what Americans have to shell out for their medicines, and directed the use of trade policy to force other nations to pay more for prescription drugs ...

I rate Halliburton as a Hold with a $21 price target based on a 2025 adjusted EPS of $2.33, reflecting bearish oil price ...